Drug Target Review2025-07-07T13:30:05
Shift Bioscience has published a new study introducing enhanced metrics and baselines for evaluating virtual cell models - boosting gene target discovery and accelerating its rejuvenation therapeutics pipeline.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-08-20T08:43:00Z
Author Dr Daniel Tillett
2026-07-08T07:58:00
Contributor Dr Nick Lynch, Dr Raminderpal Singh
2023-05-18T10:39:07
Sponsored by BPS Bioscience
2026-06-24T13:00:00
Sponsored by HUB Organoids
2026-07-21T09:36:00
Contributor Jayson Uffens, Drug Target Review
Site powered by Webvision Cloud